| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |